The 10 most shorted ASX stocks plus the biggest risers and fallers – Week 29
Short sellers covered their bearish bets against stocks like Boss Energy, James Hardie and Imugene last week.
Source: iStock
Mentioned
Welcome back to the Short Seller Series – A recap of the most heavily shorted stocks on the ASX and those experiencing significant changes to short interest over the past week.
Short selling data is four days behind today's date because reporting is not mandatory until three business days after the trade. The tables below will compare:
Week-on-week changes between 30 June and 7 July
Month-on-month changes between 6 June and 7 July
Most covered and rising short tables record week-on-week changes of 0.5% or more
Most Shorted
Ticker | Company | Short % | Week-on-Week | Month-on-Month |
|---|---|---|---|---|
PDN | Paladin Energy | 16.28% | 0.25% | 0.88% |
BOE | Boss Energy | 14.07% | -1.00% | -5.43% |
MIN | Mineral Resources | 13.84% | 0.00% | -0.75% |
PLS | Pilbara Minerals | 13.72% | 0.49% | 0.90% |
LTR | Liontown Resources | 12.58% | -0.01% | -0.05% |
IEL | Idp Education | 11.81% | 0.33% | 0.34% |
SLX | SILEX Systems | 11.22% | 0.01% | 1.36% |
PNV | Polynovo | 10.96% | 0.29% | 0.33% |
LIC | Lifestyle Communities | 10.10% | 0.06% | 0.14% |
CTD | Corporate Travel Management | 9.93% | 0.40% | 0.01% |
Key takeaways
Short interest continues to trickle out of Boss Energy, currently at the lowest level since early December 2024. This is taking place at an interesting juncture where uranium stocks are pulling back after a massive post-Liberation Day rally, while Paladin Energy has dramatically underperformed Boss Energy, though this gap is starting to slightly close.
Rising Shorts
Ticker | Company | Short % | Week-on-Week | Month-on-Month |
|---|---|---|---|---|
CU6 | Clarity Pharmaceuticals | 7.92% | 1.27% | 0.72% |
AMC | Amcor | 2.06% | 1.21% | 0.78% |
BPT | Beach Energy | 3.35% | 0.72% | 0.26% |
ALK | Alkane Resources | 2.69% | 0.56% | 1.34% |
WA1 | WA1 Resources | 2.38% | 0.56% | 0.48% |
Key takeaways
Meanwhile, Clarity Pharmaceuticals leads rising shorts with a 1.27% weekly increase, potentially reflecting clinical trial concerns or biotech sector rotation. In contrast, Amcor's short interest climbed despite a 7.6% rally between 1-9 July, coming after UBS analysts upgraded the stock from Neutral to Buy with a $18.25 target price last month. The analysts noted that while "Amcor has delivered benign EPS growth over the past three years, given destocking and inflation linked consumer pressure," a revised strategic focus on growth, underpinned by investment in high-growth consumer packaging categories, Berry merger synergies, and a more supportive capital framework should drive an FY25-FY28e EPS CAGR of 12%.
Most Covered
Ticker | Company | Short % | Week-on-Week | Month-on-Month |
|---|---|---|---|---|
IMU | Imugene | 0.00% | -5.21% | -5.24% |
JHX | James Hardie Industries | 5.57% | -4.02% | -1.09% |
BMN | Bannerman Energy | 3.95% | -1.46% | -4.58% |
BOE | Boss Energy | 14.07% | -1.00% | -5.43% |
DMP | Domino's Pizza | 5.26% | -0.77% | -4.48% |
IGO | IGO | 7.54% | -0.76% | -1.31% |
SPR | Spartan Resources | 2.33% | -0.75% | -0.44% |
DYL | Deep Yellow | 8.40% | -0.73% | -2.48% |
MP1 | Megaport | 2.31% | -0.62% | -1.95% |
WHC | Whitehaven Coal | 5.68% | -0.56% | 0.14% |
LYC | Lynas Rare Earths | 6.50% | -0.52% | -1.88% |
Key takeaways
Elsewhere, Imugene's short interest has abruptly hit zero, possibly reflecting a large shareholder recalling short positions at an intriguing time since the stock entered a trading halt on Monday, 14 July for a proposed capital raising. Similarly, James Hardie has seen its short interest aggressively fall following the company's completion of its AZEK acquisition on 1 July.
